Provided by Tiger Trade Technology Pte. Ltd.

Hancock Jaffe Laboratories Inc.

10.38
0.0000
Volume:- -
Turnover:2.30M
Market Cap:90.15M
PE:-3.83
High:10.38
Open:10.38
Low:10.38
Close:10.38
52wk High:17.68
52wk Low:4.99
Shares:8.68M
Float Shares:6.64M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7070
EPS(LYR):-7.5439
ROE:-55.76%
ROA:-30.58%
PB:2.21
PE(LYR):-1.38

Loading ...

Company Profile

Company Name:
Hancock Jaffe Laboratories Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA.